Continuous Glucose Monitoring Systems Market is predicted to reach USD 25.8 billion at a CAGR of 12.34% during the forecast period 2024-2032

Market Research Future (MRFR) has published on the “Global Continuous Glucose Monitoring Systems Market”.

The Continuous Glucose Monitoring Systems market is estimated to register a CAGR of 12.34% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global Continuous Glucose Monitoring Systems market— Dexcom, Inc (US), A.Menarini Diagnostics SRL (Italy), Sensonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc. (US), Ultrahuman Healthcare Pvt Ltd (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), and Sinocare (China).

Market Highlights

The global Continuous Glucose Monitoring Systems market is accounted for to register a CAGR of 12.34% during the forecast period and is estimated to reach USD 25.8 billion by 2032.

The global continuous glucose monitoring systems market is significantly influenced by the rising awareness among individuals about the invaluable benefits of continuous glucose monitoring, coupled with ongoing patient education initiatives. As awareness campaigns gain momentum, individuals are becoming increasingly proactive in managing their diabetes, leading to a higher demand for continuous glucose monitoring systems devices. For instance, in October 2023, Ascensia Diabetes Care (Switzerland) and Senseonics (US) launched 'The CGM for Real Life'. The campaign aims to spotlight the true experiences of individuals with diabetes, showcasing their daily complexities, successes, and challenges.

Segment Analysis

The global continuous glucose monitoring systems market has been segmented based on product, application and end user.

On the basis of the product, the market is segmented into sensors and transmitter and receivers. The sensors segment was attributed to holding the largest market share in 2023 revenue as estimated by MRFR analysis.

On the basis of the application, the market is segmented into type 2 diabetes, type 1 diabetes, and non-diabetic patients. Non-diabetic patients is further segmented into weight loss, diet management, and health and wellness. The weight loss segment was attributed to holding the largest market share in 2023 revenue as estimated by MRFR analysis

On the basis of the end user, the market is segmented into hospitals & clinics, homecare settings and others. The homecare settings segment held the majority share in 2023 of the global Continuous Glucose Monitoring Systems market revenue.

Explore In-depth Details: Continuous Glucose Monitoring Systems Market Research Report

Regional Analysis

The global Continuous Glucose Monitoring Systems market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of US and Canada. The Europe Continuous Glucose Monitoring Systems market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The Continuous Glucose Monitoring Systems market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia-Pacific. The Rest of the world’s Continuous Glucose Monitoring Systems market comprises of Middle East & Africa, and Latin America.

The North America continuous glucose monitoring systems market is experiencing robust growth, driven by technological advancements and a rising prevalence of diabetes in the region. According to the center of disease control and prevention (CDC), in 2020, approximately 34.2 million people in the United States had diabetes among others drive the growth of the market are expected to support market growth.

Moreover, the Europe market has been persistently growing owing to to increasing prevalence of diabetes in the region, and advancements in CGM technology.

Additionally, market factors, such as the large and diverse population providing a significant market for Continuous Glucose Monitoring Systems, and rising prevalence of diabetes are driving the Asia-Pacific region’s growth.

Furthermore, the rest of the world's patient portal market is divided into the Middle East & Africa, and Latin America. The Middle East region is the major contributor to the market. the increasing awareness about advanced glucose monitoring systems, has been driving the market growth have driven the market growth in the Middle East & Africa.

Key Findings of the Study

• The global Continuous Glucose Monitoring Systems market is expected to reach USD 25.8 billion by 2032, at a CAGR of 12.34% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market, owing to large and diverse population providing a significant market for Continuous Glucose Monitoring Systems, and rising prevalence of diabetes.


• Based on product the sensors segment was attributed to holding the largest market in 2023.


• Dexcom, Inc (US), A.Menarini Diagnostics SRL (Italy), Sensonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc. (US), Ultrahuman Healthcare Pvt Ltd (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), and Sinocare (China) are the key market players.